4
Changes in Ownership
Heartflow, Inc. Filed Acc 0001464521-26-000052
Chief Medical Officer sold 64,533 shares at $24.64 ($1,590,093)
- Chief Medical Officer acquired 67,017 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rogers Campbell Chief Medical Officer | 2026-04-01 | Option exercise 10b5-1 | +291 | $8.33 | $2,424 | 78,809 | D |
| Rogers Campbell Chief Medical Officer | 2026-04-01 | Option exercise 10b5-1 | +19,111 | $2.22 | $42,426 | 97,920 | D |
| Rogers Campbell Chief Medical Officer | 2026-04-01 | Option exercise 10b5-1 | +40,766 | $2.22 | $90,501 | 138,686 | D |
| Rogers Campbell Chief Medical Officer | 2026-04-01 | Option exercise 10b5-1 | +6,849 | $2.22 | $15,205 | 145,535 | D |
| Rogers Campbell Chief Medical Officer | 2026-04-01 | Sale 10b5-1 | −64,533 | $24.64 | $1,590,093 | 81,002 | D |
| Derivatives | |||||||
| Rogers Campbell Chief Medical Officer | 2026-04-01 | Option exercise · Stock Options 10b5-1 | −6,849 | 0 | D | ||
| Rogers Campbell Chief Medical Officer | 2026-04-01 | Option exercise · Stock Option 10b5-1 | −291 | 3,298 | D | ||
| Rogers Campbell Chief Medical Officer | 2026-04-01 | Option exercise · Stock Option 10b5-1 | −19,111 | 122,399 | D | ||
| Rogers Campbell Chief Medical Officer | 2026-04-01 | Option exercise · Stock Option 10b5-1 | −40,766 | 81,633 | D | ||
| Open-market sales · 64,533 sh · avg $24.64 · $1,590,093 | |||||||
Loading xslF345X06/form4.xml…